Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8653033 | TERSERA | Method for administering omega-conopeptide |
Oct, 2024
(1 year, 8 months from now) | |
US8765680 | TERSERA | Method for administering omega-conopeptide |
Oct, 2024
(1 year, 8 months from now) | |
US9707270 | TERSERA | Method for administering ω-conopeptide |
Oct, 2024
(1 year, 8 months from now) |
Market Authorisation Date: 28 December, 2004
Treatment: Analgesia; Treatment of pain; Treatment of severe chronic pain via intrathecal infusion of ziconotide in patients also receiving morphine
Dosage: INJECTABLE;INTRATHECAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic